Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics von Onstenk, W, Gratama, J.W, Foekens, J.A, Sleijfer, S

Volltext

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer von Coebergh van den Braak, R R J, Ten Hoorn, S, Sieuwerts, A M, Tuynman, J B, Smid, M, Wilting, S M, Martens, J W M, Punt, C J A, Foekens, J A, Medema, J P, IJzermans, J N M, Vermeulen, L

Volltext

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA von Weerts, M.J.A., Timmermans, E.C., van de Stolpe, A., Vossen, R.H.A.M., Anvar, S.Y., Foekens, J.A., Sleijfer, S., Martens, J.W.M.

Volltext

Methylated genes as new cancer biomarkers von Duffy, M.J, Napieralski, R, Martens, J.W.M, Span, P.N, Spyratos, F, Sweep, F.C.G.J, Brunner, N, Foekens, J.A, Schmitt, M

Volltext

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer von Godinho, M F E, Sieuwerts, A M, Look, M P, Meijer, D, Foekens, J A, Dorssers, L C J, van Agthoven, T

Volltext

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer von Reijm, E.A., Timmermans, A.M., Look, M.P., Meijer-van Gelder, M.E., Stobbe, C.K., van Deurzen, C.H.M., Martens, J.W.M., Sleijfer, S., Foekens, J.A., Berns, P.M.J.J., Jansen, M.P.H.M.

Volltext

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer von Uhr, K., Sieuwerts, A. M., de Weerd, V., Smid, M., Hammerl, D., Foekens, J. A., Martens, J. W. M.

Volltext

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer von Jansen, M. P. H. M., Reijm, E. A., Sieuwerts, A. M., Ruigrok-Ritstier, K., Look, M. P., Rodríguez-González, F. G., Heine, A. A. J., Martens, J. W., Sleijfer, S., Foekens, J. A., Berns, E. M. J. J.

Volltext

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib von Godinho, M F E, Wulfkuhle, J D, Look, M P, Sieuwerts, A M, Sleijfer, S, Foekens, J A, Petricoin, E F, Dorssers, L C J, van Agthoven, T

Volltext

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients von Mostert, B., Sieuwerts, A.M., Kraan, J., Bolt-de Vries, J., van der Spoel, P., van Galen, A., Peeters, D.J., Dirix, L.Y., Seynaeve, C.M., Jager, A., de Jongh, F.E., Hamberg, P., Stouthard, J.M.L., Kehrer, D.F.S., Look, M.P., Smid, M., Gratama, J.W., Foekens, J.A., Martens, J.W.M., Sleijfer, S.

Volltext

Using second harmonic generation to predict patient outcome in solid tumors von Burke, K, Smid, M, Dawes, R P, Timmermans, M A, Salzman, P, van Deurzen, C H M, Beer, David G, Foekens, J A, Brown, E

Volltext

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways von Yang, F, Foekens, J A, Yu, J, Sieuwerts, A M, Timmermans, M, Klijn, J G M, Atkins, D, Wang, Y, Jiang, Y

Volltext

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer von Reijm, E. A, Jansen, M. P. H. M, Ruigrok-Ritstier, K, van Staveren, I. L, Look, M. P, van Gelder, M. E. Meijer, Sieuwerts, A. M, Sleijfer, S, Foekens, J. A, Berns, E. M. J. J

Volltext

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations von Span, P.N., Pollakis, G., Paxton, W.A., Sweep, F.C.G.J., Foekens, J.A., Martens, J.W.M., Sieuwerts, A.M., van Laarhoven, H.W.M.

Volltext

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients von KRAAN, J., STRIJBOS, M. H., SIEUWERTS, A. M., FOEKENS, J. A., DEN BAKKER, M. A., VERHOEF, C., SLEIJFER, S., GRATAMA, J. W.

Volltext

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients von FOEKENS, J. A, PETERS, H. A, VAN PUTTEN, W. L. J, KLIJN, J. G. M, LOOK, M. P, PORTENGEN, H, SCHMITT, M, KRAMER, M. D, BRÜNNER, N, JÄNICKE, F, MEIJER-VAN GELDER, M. E, HENZEN-LOGMANS, S. C

Volltext

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer von van Agthoven, T, Sieuwerts, A M, Veldscholte, J, Meijer-van Gelder, M E, Smid, M, Brinkman, A, den Dekker, A T, Leroy, I M, van IJcken, W F J, Sleijfer, S, Foekens, J A, Dorssers, L C J

Volltext

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients von EPPENBERGER, U, KUENG, W, SCHMITT, M, FOEKENS, J. A, EPPENBERGER-CASTORI, S, SCHLAEPPI, J.-M, ROESEL, J. L, BENZ, C, MUELLER, H, MATTER, A, ZUBER, M, LUESCHER, K, LITSCHGI, M

Volltext

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas von Fina, F, Romain, S, Ouafik, L'H, Palmari, J, Ayed, F Ben, Benharkat, S, Bonnier, P, Spyratos, F, Foekens, J A, Rose, C, Buisson, M, Gérard, H, Reymond, M O, Seigneurin, J M, Martin, P M

Volltext

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients von Foekens, J A, Look, M P, Vries, J Bolt-de, Gelder, M E Meijer-van, Putten, W L J van, Klijn, J G M

Volltext